Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Tack

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The American Journal of Medicine|August 1, 1982
Aspergillus osteomyelitis. Report of four cases and review of the literatureK J Tack, F S Rhame, B Brown, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study GroupK J Tack, C H Keyserling, J McCarty, et al.
The Pediatric Infectious Disease Journal|January 6, 2001
Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis mediaS L Block, J Kratzer, M A Nemeth, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
Comparison of cefdinir and cefaclor in treatment of community-acquired pneumoniaM Drehobl, P Bianchi, C H Keyserling, et al.
Chemotherapy|January 1, 1984
Antibiotic susceptibility of community hospital blood culture isolates of gram-negative bacilliR C Gordon, K J Tack, R I Haddy, et al.
Clinical Therapeutics|May 20, 1998
Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study GroupK J Tack, T W Littlejohn, G Mailloux, et al.
Clinical Therapeutics|July 1, 1996
Efficacy and safety of cefdinir in the treatment of patients with acute bronchitis. The Cefdinir Bronchitis Study GroupM J Sperling, A Puopolo, T J Griffin, et al.
The Pediatric Infectious Disease Journal|January 6, 2001
Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacyS L Block, J A Hedrick, J Kratzer, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1987
Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effectsS L Gregoire, T H Grasela, J P Freer, et al.
Clinical Therapeutics|August 17, 2000
Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infectionA P Leigh, M A Nemeth, C H Keyserling, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The American Journal of Medicine|August 1, 1982
Aspergillus osteomyelitis. Report of four cases and review of the literatureK J Tack, F S Rhame, B Brown, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study GroupK J Tack, C H Keyserling, J McCarty, et al.
The Pediatric Infectious Disease Journal|January 6, 2001
Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis mediaS L Block, J Kratzer, M A Nemeth, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
Comparison of cefdinir and cefaclor in treatment of community-acquired pneumoniaM Drehobl, P Bianchi, C H Keyserling, et al.
Chemotherapy|January 1, 1984
Antibiotic susceptibility of community hospital blood culture isolates of gram-negative bacilliR C Gordon, K J Tack, R I Haddy, et al.
Clinical Therapeutics|May 20, 1998
Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study GroupK J Tack, T W Littlejohn, G Mailloux, et al.
Clinical Therapeutics|July 1, 1996
Efficacy and safety of cefdinir in the treatment of patients with acute bronchitis. The Cefdinir Bronchitis Study GroupM J Sperling, A Puopolo, T J Griffin, et al.
The Pediatric Infectious Disease Journal|January 6, 2001
Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacyS L Block, J A Hedrick, J Kratzer, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1987
Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effectsS L Gregoire, T H Grasela, J P Freer, et al.
Clinical Therapeutics|August 17, 2000
Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infectionA P Leigh, M A Nemeth, C H Keyserling, et al.
Pageof 4